These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 36451892)

  • 1. Comparative aerosol and surface stability of SARS-CoV-2 Variants of Concern.
    Bushmaker T; Yinda CK; Morris DH; Holbrook MG; Gamble A; Adney D; Bushmaker C; van Doremalen N; Fischer RJ; Plowright RK; Lloyd-Smith JO; Munster VJ
    bioRxiv; 2022 Nov; ():. PubMed ID: 36451892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Aerosol and Surface Stability of SARS-CoV-2 Variants of Concern.
    Bushmaker T; Yinda CK; Morris DH; Holbrook MG; Gamble A; Adney D; Bushmaker C; van Doremalen N; Fischer RJ; Plowright RK; Lloyd-Smith JO; Munster VJ
    Emerg Infect Dis; 2023 May; 29(5):1033-1037. PubMed ID: 37054984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ancestral Lineage of SARS-CoV-2 Is More Stable in Human Biological Fluids than Alpha, Beta, and Omicron Variants of Concern.
    Kwon T; Gaudreault NN; Meekins DA; McDowell CD; Cool K; Richt JA
    Microbiol Spectr; 2023 Feb; 11(1):e0330122. PubMed ID: 36688691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Variants in the Ferret Model.
    Pulit-Penaloza JA; Belser JA; Sun X; Pappas C; Brock N; Kieran TJ; Ritter JM; Seixas JN; Jones J; Basu Thakur P; Pusch E; Wang L; Tumpey TM; Wentworth DE; Zhou B; Maines TR
    mBio; 2022 Oct; 13(5):e0242122. PubMed ID: 36135377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in environmental stability among SARS-CoV-2 variants of concern: both omicron BA.1 and BA.2 have higher stability.
    Hirose R; Itoh Y; Ikegaya H; Miyazaki H; Watanabe N; Yoshida T; Bandou R; Daidoji T; Nakaya T
    Clin Microbiol Infect; 2022 Nov; 28(11):1486-1491. PubMed ID: 35640841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants.
    Banerjee A; Lew J; Kroeker A; Baid K; Aftanas P; Nirmalarajah K; Maguire F; Kozak R; McDonald R; Lang A; Gerdts V; Straus SE; Gilbert L; Li AX; Mozafarihashjin M; Walmsley S; Gingras AC; Wrana JL; Mazzulli T; Colwill K; McGeer AJ; Mubareka S; Falzarano D
    Med; 2022 Jun; 3(6):422-432.e3. PubMed ID: 35437520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis.
    Mastrorosa I; Cozzi-Lepri A; Colavita F; Lalle E; Mazzotta V; Cimaglia C; Paulicelli J; Matusali G; Fabeni L; Carletti F; Rosati S; Vita S; Giannico G; Piselli P; Biliotti E; Moghazi SA; Mosti S; Girardi E; Nicastri E; Garbuglia AR; Maggi F; Vaia F; Antinori A
    J Clin Virol; 2022 Dec; 157():105299. PubMed ID: 36183546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covid-19 variants: Impact on transmissibility and virulence.
    Malik YA
    Malays J Pathol; 2022 Dec; 44(3):387-396. PubMed ID: 36591708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple model to estimate the transmissibility of the Beta, Delta, and Omicron variants of SARS-COV-2 in South Africa.
    Yu Y; Yu Y; Zhao S; He D
    Math Biosci Eng; 2022 Jul; 19(10):10361-10373. PubMed ID: 36031998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited Cross-Variant Immunity after Infection with the SARS-CoV-2 Omicron Variant Without Vaccination.
    Suryawanshi RK; Chen IP; Ma T; Syed AM; Brazer N; Saldhi P; Simoneau CR; Ciling A; Khalid MM; Sreekumar B; Chen PY; Kumar GR; Montano M; Garcia-Knight MA; Sotomayor-Gonzalez A; Servellita V; Gliwa A; Nguyen J; Silva I; Milbes B; Kojima N; Hess V; Shacreaw M; Lopez L; Brobeck M; Turner F; Soveg FW; George AF; Fang X; Maishan M; Matthay M; Greene WC; Andino R; Spraggon L; Roan NR; Chiu CY; Doudna J; Ott M
    medRxiv; 2022 Feb; ():. PubMed ID: 35075459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OraSure InteliSwab
    Weishampel ZA; Young J; Fischl M; Fischer RJ; Donkor IO; Riopelle JC; Schulz JE; Port JR; Saturday TA; van Doremalen N; Berry JD; Munster VJ; Yinda CK
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability and transmissibility of SARS-CoV-2 in the environment.
    Geng Y; Wang Y
    J Med Virol; 2023 Jan; 95(1):e28103. PubMed ID: 36039831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants.
    Trobajo-Sanmartín C; Martínez-Baz I; Miqueleiz A; Fernández-Huerta M; Burgui C; Casado I; Baigorría F; Navascués A; Castilla J; Ezpeleta C
    Microbiol Spectr; 2022 Apr; 10(2):e0000822. PubMed ID: 35412379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after Vaccination.
    Takheaw N; Liwsrisakun C; Chaiwong W; Laopajon W; Pata S; Inchai J; Duangjit P; Pothirat C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A; Tajarernmuang P; Niyatiwatchanchai N; Trongtrakul K; Kasinrerk W
    Diagnostics (Basel); 2022 May; 12(6):. PubMed ID: 35741126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants.
    Chen Y; Chen L; Yin S; Tao Y; Zhu L; Tong X; Mao M; Li M; Wan Y; Ni J; Ji X; Dong X; Li J; Huang R; Shen Y; Shen H; Bao C; Wu C
    Emerg Microbes Infect; 2022 Dec; 11(1):1524-1536. PubMed ID: 35608053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and Lower Respiratory Tract Immunity to SARS-CoV-2 Omicron and Variants in Pediatric Severe COVID-19 and Mis-C.
    Tang J; Randolph AG; Novak T; Walker TC; Loftis LL; Zinter MS; Irby K; Khurana S
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters.
    Yuan S; Ye ZW; Liang R; Tang K; Zhang AJ; Lu G; Ong CP; Man Poon VK; Chan CC; Mok BW; Qin Z; Xie Y; Chu AW; Chan WM; Ip JD; Sun H; Tsang JO; Yuen TT; Chik KK; Chan CC; Cai JP; Luo C; Lu L; Yip CC; Chu H; To KK; Chen H; Jin DY; Yuen KY; Chan JF
    Science; 2022 Jul; 377(6604):428-433. PubMed ID: 35737809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Antiviral Therapy in Highly-Transmissible Variants of SARS-CoV-2: A Modeling and Simulation Study.
    Schöning V; Kern C; Chaccour C; Hammann F
    Front Pharmacol; 2022; 13():816429. PubMed ID: 35222030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial.
    Lin Y; Yue S; Yang Y; Yang S; Pan Z; Yang X; Gao L; Zhou J; Li Z; Hu L; Tang J; Wu Q; Lei S; Tian Q; Wang Y; Hao Y; Xu L; Huang Q; Zhu B; Chen Y; Chen X; Ye L
    Clin Infect Dis; 2023 Feb; 76(3):e336-e341. PubMed ID: 35666466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.